Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Starting Treatment With Agonist Replacement Therapies (START)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2009 by National Institute on Drug Abuse (NIDA).
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
University of California, Los Angeles
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00315341
First received: April 16, 2006
Last updated: October 29, 2009
Last verified: October 2009